ALLHAT and ANBP2: what have we learned from recent mega-trials?
Sander
Gary E
GE
Section of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112-2825, USA.
Giles
Thomas D
TD
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001315:Australia; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D017063:Outcome Assessment, Health Care; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents